MARC GRASSO - 30 Jun 2025 Form 4 Insider Report for Kyverna Therapeutics, Inc. (KYTX)

Role: Chief Financial Officer
Signature: By: /s/ Samantha H. Eldredge, as Attorney-in-Fact
Issuer symbol: KYTX
Transactions as of: 30 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 01 Jul 2025, 20:28:49 UTC
Previous filing: 04 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GRASSO MARC	Chief Financial Officer	C/O KYVERNA THERAPEUTICS, INC., 5980 HORTON ST., STE 550, EMERYVILLE	By: /s/ Samantha H. Eldredge, as Attorney-in-Fact	01 Jul 2025	0001748894

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KYTX	Stock Option (right to buy)	Award	$0	-450,000	-50%	$0.000000	450,000	30 Jun 2025	Common Stock	450,000	$3.07	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	1/4th of the shares subject to the option shall vest on June 30, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.